AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DIGOXINE

11 registrations across 3 African markets— 8 active

Markets with DIGOXINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
DIGOXIN SOPHARMA
Comprimé sécable / 0.250 mg
🇹🇳TunisiaSOPHARMA SAexpiredMar 2014
DIGOXINE NATIVELLE
Comprimé sécable / 0.250 MG
🇹🇳TunisiaTEOFARMA S.R.LexpiredMar 2010
DIGOXINE NATIVELLE
Gouttes buvables / 5 MCG/0.1 ML
🇹🇳TunisiaTEOFARMA S.R.LexpiredMar 2010
DIGOXINE NATIVELLE
ampoule injectable / 0,5 mg / 2 ml
🇸🇳SenegalTEOFARMAactive
DIGOXINE NATIVELLE
COMPRIME SECABLE
🇲🇦Moroccoactive
DIGOXINE NATIVELLE
SOLUTION BUVABLE
🇲🇦Moroccoactive
DIGOXINE NATIVELLE
solution buvable en goutte / 5 mcg / 0,1 ml
🇸🇳SenegalTEOFARMAactive
DIGOXINE NATIVELLE
ampoule injectable / 0,5 mg / 2 ml
🇸🇳SenegalTEOFARMAactive
DIGOXINE NATIVELLE
comprimé / 0,25 mg
🇸🇳SenegalTEOFARMAactive
DIGOXINE NATIVELLE
comprimé / 0,25 mg
🇸🇳SenegalTEOFARMAactive
DIGOXINE NATIVELLE
solution buvable en goutte / 5 mcg / 0,1 ml
🇸🇳SenegalTEOFARMAactive

DIGOXINE in Africa — Regulatory Overview

DIGOXINE is registered across 3 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Tunisia, Morocco. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 8 (73%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.